Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 7/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 7/20 | 0.43 |
| ▸ | SLC1A3 | P43003 | 6/20 | 0.43 |
| ▸ | GRIK1 | P39086 | 9/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | GRIK2 | Q13002 | 5/20 | 0.39 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.39 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.39 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.39 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.39 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8149690 | 1.00 | SLC7A5 (0.47) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| Water SCHEMBL5802437 | 0.98 | SLC7A5 (0.46) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| Water SCHEMBL7949254 | 0.98 | SLC7A5 (0.46) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| SCHEMBL10618085 | 0.90 | SLC7A5 (0.39) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| SCHEMBL38111 | 0.87 | GRIK1 (0.47) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| SCHEMBL2024581 | 0.87 | GRIK1 (0.47) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| SCHEMBL38112 | 0.87 | GRIK1 (0.47) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| SCHEMBL10620089 | 0.86 | SLC7A5 (0.36) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| Methane SCHEMBL15302681 | 0.85 | GRIK1 (0.46) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| Hydrochloric Acid SCHEMBL6361420 | 0.85 | GRIK1 (0.46) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116514679-A | Palladium-catalyzed sp with low-cost and high-efficiency quaternary ammonium nitrate as oxidant 2 And sp (sp) 3 Carbon hydrogen bond alkenylation method | 南京工业大学 | 2023-08-01 | — | — | CN | claimed |
| CN-109111915-B | Amino benzopyran cyanine fluorescent dye and probe, and synthetic method and application thereof | 湖南大学 | 2021-04-13 | — | — | CN | claimed |
| EP-4702033-A1 | DESMURAMYLPEPTIDE DIACIDS AS NOD2 AGONISTS AND USE THEREOF | Imhotex Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| EP-4043447-B1 | HALOGENATED TETRACYCLIC TRITERPENE DERIVATIVE, PREPARATION AND APPLICATION THEREOF | SHANGHAI QINGDONG BIOTECHNOLOGY CO LTD (CN) | 2026-01-21 | — | — | EP | disclosed |
| US-20250340916-A1 | METHOD FOR SYNTHESIZING PEPTIDES IN CELL-FREE TRANSLATION SYSTEM | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2025-11-06 | — | — | US | disclosed |
| US-12391971-B2 | Method for synthesizing peptides in cell-free translation system | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-08-19 | — | — | US | disclosed |
| EP-3980400-B1 | PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS | UNIV EMORY (US) | 2025-08-06 | — | — | EP | disclosed |
| US-12268723-B2 | Peptidomimetics for the treatment of coronavirus and picorna virus infections | EMORY UNIVERSITY (US) | 2025-04-08 | — | — | US | disclosed |
| US-20250108048-A1 | STING AGONIST COMPOUNDS AND CONJUGATES | SUTRO BIOPHARMA, INC. | 2025-04-03 | — | — | US | disclosed |
| US-12221459-B2 | Cancer treatment with (2,2-bishydroxymethyl) methylenecyclopropane nucleotides | MEDIVIR AB (SE) | 2025-02-11 | — | — | US | disclosed |
| WO-2025029832-A2 | STING AGONIST COMPOUNDS AND CONJUGATES | SUTRO BIOPHARMA, INC. (US) | 2025-02-06 | — | — | WO | disclosed |
| US-4338305-A | LUTEINIZING HORMONE RELEASING HORMONE; CONTRACEPTIVES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1982-07-06 | — | — | US | disclosed |
| US-4272432-A | Claudogenic-interceptive nonapeptide | AMERICAN HOME PRODUCTS CORPORATION (US) | 1981-06-09 | — | — | US | disclosed |
| US-4260681-A | Reagent system and method for assaying peptidase enzymes | CALBIOCHEM-BEHRING CORP. (US) | 1981-04-07 | — | — | US | disclosed |
| US-4171412-A | COPOLYMER OF HYDROXYALKYLAMIDE OR HYDROXYALKYL ESTER OF ACRYLIC OR METHACRYLIC ACID AND CROSSLINKING ETHYLENE GLYCOL DIACRYLATE OR DIMETHACRYLATE | CESKOSLOVENSKA AKADEMIE VED (CS) | 1979-10-16 | — | — | US | disclosed |
| US-4146614-A | TREATMENT OF SCHIZOPHRENIA | STATE OF MICHIGAN (US) | 1979-03-27 | — | — | US | disclosed |
| US-4086220-A | GASTRIC ANTISECRETORY AGENTS | G. D. SEARLE & CO. (US) | 1978-04-25 | — | — | US | disclosed |
| US-4082736-A | NOVEL IMMUNOLOGICAL ADJUVANT COMPOUNDS AND METHODS OF PREPARATION THEREOF | SYNTEX (U.S.A.) INC. (US) | 1978-04-04 | — | — | US | disclosed |
| US-4082735-A | NOVEL IMMUNOLOGICAL ADJUVANT COMPOUNDS AND METHODS OF PREPARATION THEREOF | SYNTEX (U.S.A.) INC. (US) | 1978-04-04 | — | — | US | disclosed |
| US-3992530-A | [D-2-(1,4-Cyclohexadienyl)gly]6 -des-gly10 -lrh nonapeptide amides | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250108048-A1 | STING AGONIST COMPOUNDS AND CONJUGATES | STING1, CGAS, MAVS | SLC7A5 2949/4885SLC1A2 4649/4885SLC1A1 4282/4885 |
| US-12391971-B2 | Method for synthesizing peptides in cell-free translation system | AARS1, NSUN3, RNGTT | SLC7A5 639/4885SLC1A2 1403/4885SLC1A1 891/4885 |
| US-12221459-B2 | Cancer treatment with (2,2-bishydroxymethyl) methylenecyclopropane nucleotides | PNP, NUDT1, TYMP | SLC7A5 594/4885SLC1A2 984/4885SLC1A1 786/4885 |
| US-12268723-B2 | Peptidomimetics for the treatment of coronavirus and picorna virus infections | ACE2, SARS1, HAVCR2 | SLC7A5 4787/4885SLC1A2 4296/4885SLC1A1 4032/4885 |
| US-20250340916-A1 | METHOD FOR SYNTHESIZING PEPTIDES IN CELL-FREE TRANSLATION SYSTEM | AARS1, NSUN3, RNGTT | SLC7A5 639/4885SLC1A2 1403/4885SLC1A1 891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.